Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus - Related Studies

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

This study is currently recruiting participants.

Study NCT00007358. Last updated on April 25, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Congenital Heart Block
		Neonatal Lupus
		Atrioventricular Nodal Dysfunction
		Myocardial Injury

2	Additional conditions recognized in this trial
		Heart Block

3	More general conditions related to this trial
		Arrhythmias, Cardiac
		Cardiovascular Diseases
		Heart Diseases
		Pathologic Processes

4	Additional drug interventions recognized in this trial
		Dexamethasone
		Dexamethasone acetate

5	More general drug interventions related to this trial
		Anti-Inflammatory Agents
		Antiemetics
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Autonomic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)